Complaint
| Early onset | Mid-oneset | Late treatment | |
| IgM | 51.28% (40/78) | 81.69%(58/71) | 92.11%(35/38) |
| IgG | 43.59% (34/78) | 78.87%(56/71) | 84.21%(32/38) |
| Total | 57.69% (45/78) | 91.55%(65/71) | 94.74%(36/38) |
1. What is the test principle?
The test principle is antigen detect.
Jiangsu Konsung Bio-medical Science and Technology Co., Ltd established in 2005. Konsung has a production base in Danyang, Jiangsu, and R&D center in Shenzhen. The main products of Konsung includes the multi parameter monitor, mobile health monitor, urine analyzer, oxygen concentrator, blood pressure monitor, wearable health equipment...Konsung also provide one stop solution service for Tele-medical system. Konsung has been approved by complete medical qualified certification. ISO9001: 2008 Quality management system certification,ISO13485: 2003 Medical management system certification,ISO14001 Environmental management system certification, FDA certification of the United States,CE certification by TUV/SGS and other authoritative approved.Konsung staffs will be full of passion and energy, adhere the sacred mission of public health and smile!
Year 2015, Acquired Double Soft Certification, information system integration & service qualification and become High-tech enterprises, Year 2016, Awarded China Medical Device Golden Tripod Award - Technology Award, Year 2017, Awarded the Title of Private technology enterprises, Year 2018, Won the Second Prize of the Second National Grassroots Informatization Application Innovation Competition (Internet of Things, Hardware Artificial Intelligence Equipment), and the Most Potential Award (Big Data, Software Information)
